Barco introduces new projection system

TriMed Staff | | Health Imaging | Screening
Barco this week released two next-generation medical grade projection systems, DICOM Theater Lite and DICOM Theater Pro, for use in medical review and conferencing environments. Both are designed for PACS viewing, but also display other sources, such as endoscopy and ultrasound, according to the Kortrijk, Belgium-based company.

Barco's DICOM Theater Lite combines high brightness and a native SXGA+ resolution (1400x1050) in a user-friendly, portable design. The system delivers projections high contrast (2000:1), comfortable light output (2000 Ansi Lumen) and optimum crispness.

DICOM Theater Pro is Barco's new top-of-the-line medical projection system that bundles a powerful MGP 15 projector and MEDICAL Pro QA software. The system can also be combined with one or more flat panel displays to provide a complete system, Barco said. Barco touts the projector's integrated smart dual lamp design and advanced high-resolution Poly-Si LCD technology that guarantee brightness (4500 Ansi Lumen) and sharp details. In addition, DICOM Theater Pro integrates Barco's I-Guard sensor technology for ensured DICOM conformance to the projected images.

Both projections systems are equipped with Barco's BarcoMed display controller for seamless connectivity to PACS workstations.

TriMed Staff

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.